250 The second RCT reported in a much larger sample (131 BCG patients, 134 placebo patients) no differences in response rate between treatment arms (21% in the BCG group compared to 12% in the placebo groups) at seven months with 95% of patients in each group reporting at least one AE
Elderly people due to impaired intestinal absorption and children, premenopausal women, and pregnant women whose diets are low in animal foods are all at increased risk
Can I stack BPC-157 with TB-500
BPC-157 Route Selection Oral BPC-157 (250 to 500 mcg, 1 to 2 times daily on an empty stomach): Best for patients whose primary goal is GI support during GLP-1 therapy
A commenter stated that if CMS recognizes additional accreditors, such organizations should be required to: (1) Publish transparent standards and conflict-of-interest safeguards
Besides, BPC 157 has neuroprotective effects: protects somatosensory neurons